Recruiting IBS Studies in Miami
Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years
This is a randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability of tenapanor (25 mg and 50 mg) in pediatric patients (≥12 and \<18 years old) with IBS-C wh...
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
The primary objectives of this study are to explore the therapeutic effect of eluxadoline in treating irritable bowel syndrome with diarrhea (IBS-D) in pediatric participants 6-17 years of age, to eva...
About IBS Clinical Trials in Miami
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder causing abdominal pain, bloating, and altered bowel habits. It affects 10-15% of the global population. Management includes dietary changes (low FODMAP diet), stress management, and medications targeting specific symptoms.
There are currently 2 ibs clinical trials recruiting participants in Miami, FL. These studies are seeking a combined 275 participants. Research is being sponsored by Ardelyx, AbbVie. Clinical trial participation is free and participants receive study-related medical care at no cost.
IBS Clinical Trials in Miami — FAQ
Are there ibs clinical trials in Miami?
Yes, there are 2 ibs clinical trials currently recruiting in Miami, FL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Miami?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami research site will contact you about next steps.
Are clinical trials in Miami free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miami studies also compensate for your time and travel.
What ibs treatments are being tested?
The 2 active trials in Miami are testing new therapies including novel drugs, biologics, and treatment approaches for ibs.
Data updated March 2, 2026 from ClinicalTrials.gov